PURPOSE: To assess motor performance among Czech paediatric off therapy patients of acute lymphoblastic leukaemia (ALL) and to compare their data with normative data. METHODS: Thirty-nine off therapy patients (21 girls, 18 boys; aged 4-21 years) were evaluated using the Complete Form of the Bruininks-Oseretsky Test Second Edition (BOT-2 CF) approximately 1.5 years post-therapy cessation. Gross and fine motor skills were assessed. Normative data from BOT-2 CF served as the basis for comparison. RESULTS: The total motor composite (p = .381, Cohen's d = 0.14) and overall fine (p = .743; Cohen's d = 0.05) and gross (p=.312; Cohen's d = 0.16) motor performance were similar to the normative data. Motor deficits in manual coordination (p = .018; Cohen's d = 0.45), strength and agility (p = .012; Cohen's d = 0.51), manual dexterity (p < .001; Cohen's d = 0.59) and running speed and agility (p < .001; Cohen's d = 0.97) were identified, along with performance better than the established norms on fine motor integration (p = .048; Cohen's d = 0.33) and bilateral coordination (p = .018; Cohen's d = 0.47). CONCLUSION: The findings suggest nuanced motor skill outcomes in ALL off therapy patients, with both deficits and strengths observed. Comprehensive assessments are vital for tailoring rehabilitation strategies to address the varied impacts of ALL and its treatment on motor skills.

3rd Faculty of Medicine Charles University Prague Czech Republic

Department of Rehabilitation and Sports Medicine 2nd Faculty of Medicine Charles University and University Hospital Motol Prague Czech Republic

Edson College of Nursing and Health Innovation Arizona State University Phoenix Arizona USA

Institute for the Care of Mother and Child Prague Czech Republic

International Clinical Research Center Brno Czech Republic

See more in PubMed

Jemal A, Ward EM, Johnson CJ, et al. . Annual report to the nation on the status of cancer, 1975–2014, featuring survival. JNCI J Natl Cancer Inst. 2017;109:djx030. PubMed PMC

Kato M, Manabe A.. Treatment and biology of pediatric acute lymphoblastic leukemia. Pediatr Int. 2018;60(1):4–12. doi: 10.1111/ped.13457. PubMed DOI

Akyay A, Olcay L, Sezer N, et al. . Muscle strength, motor performance, cardiac and muscle biomarkers in detection of muscle side effects during and after acute lymphoblastic leukemia treatment in children. J Pediatr Hematol Oncol. 2014;36(8):594–598. doi: 10.1097/MPH.0000000000000067. PubMed DOI

Mody R, Li S, Dover DC, et al. . Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Blood. 2008;111(12):5515–5523. doi: 10.1182/blood-2007-10-117150. PubMed DOI PMC

Inaba H, Pui C-H.. Glucocorticoid use in acute lymphoblastic leukaemia. Lancet Oncol. 2010;11(11):1096–1106. doi: 10.1016/S1470-2045(10)70114-5. PubMed DOI PMC

Kuhlen M, Kunstreich M, Krull K, et al. . Osteonecrosis in children and adolescents with acute lymphoblastic leukemia: a therapeutic challenge. Blood Adv. 2017;1(14):981–994. doi: 10.1182/bloodadvances.2017007286. PubMed DOI PMC

Haddy TB, Mosher RB, Reaman GH.. Osteoporosis in survivors of acute lymphoblastic leukemia. Oncologist. 2001;6(3):278–285. doi: 10.1634/theoncologist.6-3-278. PubMed DOI

Li G-Z, Hu Y-H, Li D-Y, et al. . Vincristine-induced peripheral neuropathy: a mini-review. Neurotoxicology. 2020;81:161–171. doi: 10.1016/j.neuro.2020.10.004. PubMed DOI

Orgel E, Sea JL, Mittelman SD.. Mechanisms by which obesity impacts survival from acute lymphoblastic leukemia. J Natl Cancer Inst Monogr. 2019;2019(54):152–156. doi: 10.1093/jncimonographs/lgz020. PubMed DOI PMC

Oeffinger KC, Eshelman DA, Tomlinson GE, et al. . Providing primary care for long-term survivors of childhood acute lymphoblastic leukemia. J Fam Pract. 2000;49(12):1133–1146. PubMed

van Brussel M, Takken T, van der Net J, et al. . Physical function and fitness in long-term survivors of childhood leukaemia. Pediatr Rehabil. 2006;9(3):267–274. doi: 10.1080/13638490500523150. PubMed DOI

Wright MJ, Halton JM, Martin RF, et al. . Long-term gross motor performance following treatment for acute lymphoblastic leukemia. Med Pediatr Oncol. 1998;31(2):86–90. doi: 10.1002/(SICI)1096-911X(199808)31:2<86::AID-MPO7>3.0.CO;2-V. PubMed DOI

Ness KK, DeLany JP, Kaste SC, et al. . Energy balance and fitness in adult survivors of childhood acute lymphoblastic leukemia. Blood. 2015;125(22):3411–3419. doi: 10.1182/blood-2015-01-621680. PubMed DOI PMC

Hartman A, van den Bos C, Stijnen T, et al. . Decrease in peripheral muscle strength and ankle dorsiflexion as long-term side effects of treatment for childhood cancer. Pediatr Blood Cancer. 2008;50(4):833–837. doi: 10.1002/pbc.21325. PubMed DOI

Ness KK, Baker KS, Dengel DR, et al. . Body composition, muscle strength deficits and mobility limitations in adult survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2007;49(7):975–981. doi: 10.1002/pbc.21091. PubMed DOI

Hovi L, Era P, Rautonen J, et al. . Impaired muscle strength in female adolescents and young adults surviving leukemia in childhood. Cancer. 1993;72(1):276–281. doi: 10.1002/1097-0142(19930701)72:1<276::AID-CNCR2820720148>3.0.CO;2-2. PubMed DOI

Ness KK, Hudson MM, Pui C-H, et al. . Neuromuscular impairments in adult survivors of childhood acute lymphoblastic leukemia: associations with physical performance and chemotherapy doses. Cancer. 2012;118(3):828–838. doi: 10.1002/cncr.26337. PubMed DOI PMC

Galea V, Wright MJ, Barr RD.. Measurement of balance in survivors of acute lymphoblastic leukemia in childhood. Gait Posture. 2004;19(1):1–10. doi: 10.1016/s0966-6362(03)00014-6. PubMed DOI

Varedi M, McKenna R, Lamberg EM.. Balance in children with acute lymphoblastic leukemia. Pediatr Int. 2017;59(3):293–302. doi: 10.1111/ped.13141. PubMed DOI

Gilchrist LS, Tanner LR.. Short-term recovery of balance control: association with chemotherapy-induced peripheral neuropathy in pediatric oncology. Pediatr Phys Ther Off Publ Sect Pediatr Am Phys Ther Assoc. 2018;30:119–124. PubMed

Marchese V, Rock K, York T, et al. . Neuromuscular mechanisms that contribute to gross motor performance in survivors of childhood acute lymphoblastic leukemia. J Pediatr Rehabil Med. 2021;14(3):415–423. doi: 10.3233/PRM-200784. PubMed DOI PMC

Tanner LR, Hooke MC.. Improving body function and minimizing activity limitations in pediatric leukemia survivors: the lasting impact of the Stoplight Program. Pediatr Blood Cancer. 2019;66(5):e27596. doi: 10.1002/pbc.27596. PubMed DOI

Leone M, Viret P, Bui HT, et al. . Assessment of gross motor skills and phenotype profile in children 9–11 years of age in survivors of acute lymphoblastic leukemia. Pediatr Blood Cancer. 2014;61(1):46–52. doi: 10.1002/pbc.24731. PubMed DOI

Reinders-Messelink HA, Schoemaker MM, Hofte M, et al. . Fine motor and handwriting problems after treatment for childhood acute lymphoblastic leukemia. Med Pediatr Oncol. 1996;27(6):551–555. doi: 10.1002/(SICI)1096-911X(199612)27:6<551::AID-MPO8>3.0.CO;2-K. PubMed DOI

Goebel A-M, Koustenis E, Rueckriegel SM, et al. . Motor function in survivors of pediatric acute lymphoblastic leukemia treated with chemotherapy-only. Eur J Paediatr Neurol. 2019;23(2):304–316. doi: 10.1016/j.ejpn.2018.12.005. PubMed DOI

Balsamo LM, Sint KJ, Neglia JP, et al. . The association between motor skills and academic achievement among pediatric survivors of acute lymphoblastic leukemia. J Pediatr Psychol. 2016;41(3):319–328. doi: 10.1093/jpepsy/jsv103. PubMed DOI PMC

Hockenberry M, Krull K, Moore K, et al. . Longitudinal evaluation of fine motor skills in children with leukemia. J Pediatr Hematol Oncol. 2007;29:535–539. doi: 10.1097/MPH.0b013e3180f61b92. PubMed DOI

Taverna L, Tremolada M, Bonichini S, et al. . Motor skill delays in pre-school children with leukemia one year after treatment: hematopoietic stem cell transplantation therapy as an important risk factor. PLoS One. 2017;12(10):e0186787. doi: 10.1371/journal.pone.0186787. PubMed DOI PMC

De Luca CR, McCarthy M, Galvin J, et al. . Gross and fine motor skills in children treated for acute lymphoblastic leukaemia. Dev Neurorehabil. 2013;16(3):180–187. doi: 10.3109/17518423.2013.771221. PubMed DOI

Hartman A, Hop W, Takken T, et al. . Motor performance and functional exercise capacity in survivors of pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer. 2013;60(3):494–499. doi: 10.1002/pbc.24243. PubMed DOI

Ramchandren S, Leonard M, Mody RJ, et al. . Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia. J Peripher Nerv Syst. 2009;14(3):184–189. doi: 10.1111/j.1529-8027.2009.00230.x. PubMed DOI PMC

Tay CG, Lee VWM, Ong LC, et al. . Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia. Pediatr Blood Cancer. 2017;64(8):e26471. doi: 10.1002/pbc.26471. PubMed DOI

Bruininks RH, Bruininks BD.. Bruininks-Oseretsky test of motor proficiency. 2nd ed. Minneapolis, MN: NCS Pearson; 2015.

Radanović D, Đorđević D, Stanković M, et al. . Test of motor proficiency second edition (BOT-2) short form: a systematic review of studies conducted in healthy children. Child Basel Switz. 2021;8(9):787. doi: 10.3390/children8090787. PubMed DOI PMC

Spiegler BJ, Bouffet E, Greenberg ML, et al. . Change in neurocognitive functioning after treatment with cranial radiation in childhood. J Clin Oncol. 2004;22(4):706–713. doi: 10.1200/JCO.2004.05.186. PubMed DOI

Mertens AC, Yasui Y, Neglia JP, et al. . Late mortality experience in five-year survivors of childhood and adolescent cancer: the childhood cancer survivor study. J Clin Oncol. 2001;19(13):3163–3172. doi: 10.1200/JCO.2001.19.13.3163. PubMed DOI

Wuang Y-P, Su C-Y.. Reliability and responsiveness of the Bruininks–Oseretsky test of motor proficiency-second edition in children with intellectual disability. Res Dev Disabil. 2009;30(5):847–855. doi: 10.1016/j.ridd.2008.12.002. PubMed DOI

Kim SG, Kim DH.. Reliability, minimum detectable change, and minimum clinically important difference of the balance subtest of the Bruininks-Oseretsky test of motor proficiency-second edition in children with cerebral palsy. J Pediatr Rehabil Med. 2022;15(1):175–180. doi: 10.3233/PRM-190639. PubMed DOI

Lucas BR, Latimer J, Doney R, et al. . The Bruininks-Oseretsky Test of Motor Proficiency-Short Form is reliable in children living in remote Australian Aboriginal communities. BMC Pediatr. 2013;13(1):135. doi: 10.1186/1471-2431-13-135. PubMed DOI PMC

Gharaei E, Shojaei M, Daneshfar A.. The validity and reliability of the Bruininks–Oseretsky test of motor proficiency, 2nd edition brief form, in preschool children. Ann Appl Sport Sci J. 2019;7(2):3–12. doi: 10.29252/aassjournal.7.2.3. DOI

Gilchrist LS, Tanner L.. The pediatric-modified total neuropathy score: a reliable and valid measure of chemotherapy-induced peripheral neuropathy in children with non-CNS cancers. Support Care Cancer. 2013;21:847–856. PubMed

Özdemir B, Gerçeker GÖ, Özdemir EZ, et al. . Examination of the psychometric properties of pediatric-modified total neuropathy score in Turkish children with cancer. J Pediatr Nurs. 2023;69:31–37. doi: 10.1016/j.pedn.2022.12.017. PubMed DOI

Gilchrist LS, Tanner L, Hooke MC.. Measuring chemotherapy-induced peripheral neuropathy in children: development of the Ped-mTNS and pilot study results. Rehabil Oncol. 2009;27(3):7–15. doi: 10.1097/01893697-200927030-00002. DOI

Schouten SM, van de Velde ME, Kaspers GJL, et al. . Measuring vincristine-induced peripheral neuropathy in children with cancer: validation of the Dutch pediatric-modified total neuropathy score. Support Care Cancer. 2020;28(6):2867–2873. doi: 10.1007/s00520-019-05106-3. PubMed DOI PMC

Smolik S, Arland L, Hensley MA, et al. . Assessment tools for peripheral neuropathy in pediatric oncology: a systematic review from the children’s oncology group. J Pediatr Oncol Nurs. 2018;35(4):267–275. doi: 10.1177/1043454218762705. PubMed DOI PMC

Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6:65–70.

Cohen J. Statistical power analysis for the behavioral sciences. Revised ed. Orlando: Academic Press; 1985.

Brahler CJ, Donahoe-Fillmore B, Mrowzinski S, et al. . Numerous test items in the complete and short forms of the BOT-2 do not contribute substantially to motor performance assessments in typically developing ­children six to ten years old. J Occup Ther Sch Early Interv. 2012;5(1):73–84. doi: 10.1080/19411243.2012.674746. DOI

Carmosino K, Grzeszczak A, McMurray K, et al. . Test items in the complete and short forms of the BOT-2 that contribute substantially to motor performance assessments in typically developing children 6-10 years of age. Phys Ther Fac Publ. 2014;7:31–43.

Jírovec J, Musálek M, Mess F.. Test of motor proficiency second edition (BOT-2): compatibility of the complete and short form and its usefulness for middle-age school children. Front Pediatr. 2019;7:153. doi: 10.3389/fped.2019.00153. PubMed DOI PMC

Mancini V, Rudaizky D, Howlett S, et al. . Movement difficulties in children with ADHD: comparing the long‐ and short‐form Bruininks–Oseretsky test of motor proficiency—second edition (BOT‐2). Aust Occup Ther J. 2020;67(2):153–161. doi: 10.1111/1440-1630.12641. PubMed DOI

Donatelli RA. Sports-specific rehabilitation. St. Louis, MO: Churchill Livingstone; 2007.

Porter S, Wilson J, editors. A comprehensive guide to sports physiology and injury management: an interdisciplinary approach. London, New York, Oxford, Philadelphia, St Louis, Sydney: Elsevier Health Sciences; 2021.

Van De Velde ME, Kaspers GL, Abbink FCH, et al. . Vincristine-induced peripheral neuropathy in children with cancer: a systematic review. Crit Rev Oncol Hematol. 2017;114:114–130. PubMed

Kunstreich M, Kummer S, Laws H-J, et al. . Osteonecrosis in children with acute lymphoblastic leukemia. Haematologica. 2016;101(11):1295–1305. doi: 10.3324/haematol.2016.147595. PubMed DOI PMC

Te Winkel ML, Pieters R, Wind E-JD, et al. . Management and treatment of osteonecrosis in children and adolescents with acute lymphoblastic leukemia. Haematologica. 2014;99(3):430–436. doi: 10.3324/haematol.2013.095562. PubMed DOI PMC

Wright MJ, Galea V, Barr RD.. Proficiency of balance in children and youth who have had acute lymphoblastic leukemia. Phys Ther. 2005;85(8):782–790. doi: 10.1093/ptj/85.8.782. PubMed DOI

Hanna S, Elshennawy S, El‐Ayadi M, et al. . Investigating fine motor deficits during maintenance therapy in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2020;67(7):e28385. doi: 10.1002/pbc.28385. PubMed DOI

Tejeda-Castellanos X, Sánchez-Medina CM, Márquez-González H, et al. . Impairments in fine motor skills in children with Acute Lymphoblastic Leukaemia. A cross-sectional study. BMC Pediatr. 2023;23(1):513. doi: 10.1186/s12887-023-04316-3. PubMed DOI PMC